Barbara Ryan Mi Nk Therapeutics, Inc. (INKT) insider trading activity

Barbara Ryan is of MiNK Therapeutics, Inc.. Currently has a direct ownership of 22,406 shares of INKT, which is worth approximately $286,348. The most recent transaction as insider was on Dec 01, 2025, when has been sold 1,601 shares (Common Stock) at a price of $11.09 per share, resulting in proceeds of $17,755. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 22.4K

7.7% 3M change

85.1% 12M change

Total Value Held $286,348

Barbara Ryan Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 01 2025	BUY Grant, award, or other acquisition	$17,755 $11.09 p/Share	1,601 Added 6.67%	22,406 Common Stock
Sep 02 2025	BUY Grant, award, or other acquisition	$17,754 $13.86 p/Share	1,281 Added 5.8%	20,805 Common Stock
Jun 02 2025	BUY Grant, award, or other acquisition	$17,752 $7.17 p/Share	2,476 Added 11.25%	19,524 Common Stock
Mar 03 2025	BUY Grant, award, or other acquisition	$17,747 $8.79 p/Share	2,019 Added 10.59%	17,048 Common Stock
Dec 01 2024	BUY Grant, award, or other acquisition	$17,687 $0.73 p/Share	24,229 Added 13.88%	150,336 Common Stock
Sep 03 2024	BUY Grant, award, or other acquisition	$17,752 $0.82 p/Share	21,649 Added 14.65%	126,107 Common Stock
Jun 03 2024	BUY Grant, award, or other acquisition	$17,662 $0.99 p/Share	17,841 Added 14.59%	104,458 Common Stock

Mar 01 2024	BUY Grant, award, or other acquisition	$17,750 $0.95 p/Share	18,685 Added 17.74%	86,617 Common Stock
Dec 01 2023	BUY Grant, award, or other acquisition	$17,750 $1.04 p/Share	17,068 Added 20.08%	67,932 Common Stock
Sep 01 2023	BUY Grant, award, or other acquisition	$17,750 $1.46 p/Share	12,158 Added 19.29%	50,864 Common Stock
Jun 01 2023	BUY Grant, award, or other acquisition	$17,751 $1.76 p/Share	10,086 Added 20.58%	38,930 Common Stock
Mar 01 2023	BUY Grant, award, or other acquisition	$17,750 $2.09 p/Share	8,493 Added 22.75%	28,844 Common Stock
Dec 01 2022	BUY Grant, award, or other acquisition	$17,750 $2.61 p/Share	6,801 Added 25.05%	20,351 Common Stock
Sep 15 2022	BUY Grant, award, or other acquisition	$35,501 $2.62 p/Share	13,550 Added 50.0%	13,550 Common Stock

Also insider at

INVO

INVO Bioscience, Inc. Healthcare

Director

AZTR

Azitra Inc

Director

Barbara Ryan

New York, NY

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells INKT shares.

Notify only if

Value

Insider Trading

Get notified when an Mi Nk Therapeutics, Inc. insider buys or sells INKT shares.

Notify only if

Operation

Value

Type

News

Receive news related to MiNK Therapeutics, Inc.

Track Activities on INKT

Account